SPINT1
SPINT1 (serine peptidase inhibitor, Kunitz type 1) is a Kunitz-type serine protease inhibitor that restrains the activity of HGF activator and other membrane-associated proteases. It is also known as HAI, HAI-1 and MANSC2. Browse Assay Genie's current range of SPINT1 research reagents below, or read on for the biology behind the target.
SPINT1 is a serine protease inhibitor. It acts as an inhibitor of HGFAC (HGF activator), and NCBI describes it as a potent inhibitor specific for HGF activator. It is thought to be involved in regulating the proteolytic activation of HGF in injured tissues. In vitro, SPINT1 also inhibits the serine protease activity of ST14 (matriptase), and it inhibits the serine protease activity of TMPRSS13 through its BPTI/Kunitz inhibitor 1 domain.
The SPINT1 gene encodes a member of the Kunitz family of serine protease inhibitors. According to UniProt, the protein is found in the secreted fraction, in the cytoplasm and at the cell membrane. Alternative splicing of the gene produces multiple transcript variants that encode different isoforms, which is worth bearing in mind when choosing reagents for SPINT1 protein detection.
The protein is also called HAI-1 (hepatocyte growth factor activator inhibitor type 1), with HAI and MANSC2 listed as further aliases. The previous HGNC name was serine protease inhibitor, Kunitz type 1. The mouse ortholog is Spint1. Because of its role in restraining HGF activation and matriptase and TMPRSS13 activity, SPINT1 is studied in work on pericellular proteolysis and tissue injury responses.
SPINT1 inhibits HGF activator and is thought to regulate proteolytic activation of HGF in injured tissues, making it relevant to HGF pathway studies.
SPINT1 inhibits the serine protease activity of ST14/matriptase in vitro, providing a model for studying control of membrane-anchored serine proteases.
The BPTI/Kunitz inhibitor 1 domain of SPINT1 inhibits TMPRSS13, which supports research into Kunitz domain-protease specificity.
Its proposed role in regulating HGF activation in injured tissues links SPINT1 to research on proteolytic control during tissue response to damage.
SPINT1 is a Kunitz-type serine protease inhibitor. It inhibits HGF activator and is thought to help regulate the proteolytic activation of HGF in injured tissues. In vitro it also inhibits the serine protease activity of ST14/matriptase and TMPRSS13.
SPINT1 is also known as HAI, HAI-1 and MANSC2, and was previously named serine protease inhibitor, Kunitz type 1. Alternative splicing of the SPINT1 gene gives multiple variants that encode different isoforms, so check isoform coverage for your application.
A mouse ortholog, Spint1, is recorded for the human gene. Human SPINT1 is a member of the Kunitz family of serine protease inhibitors. For cross-species work, check the datasheet of any product for its validated reactivity.
Other Kunitz-type inhibitors, HGF pathway components and the membrane serine proteases regulated by SPINT1.
Gene and protein annotations from HGNC, NCBI Gene and UniProt O43278; product specifications from Assay Genie datasheets.